Netherlands · 
Who invested in Kiadis Pharma?
Kiadis Pharma's investors include Alta Partners, EQT life science, Quest for Growth, Draper Esprit and DFJ Esprit, and 2 more on record.
20082009201020112012
$20MVenture$13MVentureNetherlands · Venture startup
Who invested in Kiadis Pharma
2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$33Mraised across 2 rounds since 2007, from 2 sources
$20MVenture$13MVenture
- Latest round
- Venture, $13MNov 2012
- Biggest round
- $20MVenture · Jun 2007
- Investors
- 7
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $20M Jun 2007
- Biggest round
- $20M Venture · Jun 2007
- Between rounds
- 5.4 years from the last two
The rounds
- Nov 2012Venture$13M2 new3 returning
Reported by kiadis.com
- Jun 2007Venture$20M5 new
From a historical funding record
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
MedSciences CapitalVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Kiadis Pharma
How much has Kiadis Pharma raised?
Kiadis Pharma has raised $33M across 2 rounds since 2007.
When did Kiadis Pharma last raise?
Kiadis Pharma's most recent round was a Venture of $13M in Nov 2012.
What was Kiadis Pharma's biggest round?
Kiadis Pharma's largest round on record is $20M (Venture), in Jun 2007.
Who backed Kiadis Pharma first?
Kiadis Pharma's first round on record, in Jun 2007, was backed by Alta Partners, EQT life science and Quest for Growth and 2 others.
What stage is Kiadis Pharma at?
Kiadis Pharma's latest named round is a Venture, in Nov 2012.
Where is Kiadis Pharma based?
Kiadis Pharma is based in the Netherlands.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.